Skip to main content

Table 2 Screening thresholds for diagnosis of sarcopenia in the LACE trial

From: Leucine and ACE inhibitors as therapies for sarcopenia (LACE trial): study protocol for a randomised controlled trial

 

Males

Females

Walking speed over 4 m (m/s)

< 0.8

< 0.8

Maximum handgrip strength (kg)

< 30

< 20

Height-adjusted skeletal muscle mass:

  

  BMI < 18.5 (kg/m2)

≤ 6.02

≤ 5.25

  BMI 18.5–24.9 (kg/m2)

≤ 7.14

≤ 5.70

  BMI 25.0–29.9 (kg/m2)

≤ 8.00

≤ 6.19

  BMI ≥ 30 (kg/m2)

≤ 8.77

≤ 6.72

  1. Diagnosis requires low walking speed and/or low grip strength AND low muscle mass
  2. BMI body mass index, LACE Leucine and Angiotensin Converting Enzyme inhibitors in sarcopenia
Back to article page

Trials

ISSN: 1745-6215